Welcure Drugs & Pharmaceuticals Ltd share price logo

Welcure Drugs Share Price

BSE: 524661

Small Cap

Healthcare Sector

₹0.34

-0.01

(-2.86%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Welcure Drugs Stock Performance

as on February 17, 2026 at 9:31 pm IST

  • ₹0.34
    ₹0.34

  • 52 Week's Low

    52 Week's High

    ₹0.28
    ₹1.44
    downward going graph

    17.65%

    Downside

    323.53%

    Upside

    downward going graph

Welcure Drugs share price movements today

Previous Close
₹0.35
Open
₹0.34
Volume
13.89L
Upper Circuit
₹0.36
Lower Circuit
₹0.34
Day's Low - High
₹0.34 - ₹0.34
52 Week Low - High
₹0.28 - ₹1.44

Welcure Drugs Historical Returns

1 Month Return
-7.89 %
3 Month Return
-39.66 %
1 Year Return
-56.25 %
3 Year Return
-18.6 %
5 Year Return
+ 84.21 %

Welcure Drugs Fundamentals

as on February 17, 2026 at 4:01 pm IST

Market Cap

₹43.26 Cr

Return on Equity (ROE)

3.81

PE Ratio (TTM)

0

Return on capital employed (ROCE)

2.42

Beta (LTM)

1.05

P/B Ratio

1

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

2575

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0.51

Technical Analysis

Bearish

View Technical Analysis

Welcure Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Welcure Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Welcure Drugs & Pharmaceuticals Ltd image
Welcure Drugs & Pharmaceuticals Ltd
NA43.2616.84%0.00NANA
Panchsheel Organics Ltd image
Panchsheel Organics Ltd
NA156.3530.46%0.0013107
Fermenta Biotech Ltd image
Fermenta Biotech Ltd
NA952.982.71%0.6476469
Pentokey Organy (India) Ltd image
Pentokey Organy (India) Ltd
NA26.0224.03%0.0034
Novartis India Ltd image
Novartis India Ltd
NA2,037.366.74%0.00100390
See all

Welcure Drugs Share Price Target

Get share price movements and forecasts by analysts on Welcure Drugs.

Source: S&P Global Market Intelligence

Welcure Drugs Stock’s Investor Sentiment and Interest

Investment in Welcure Drugs & Pharmaceuticals Ltd Shares on INDmoney has dropped by -32.75% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-32.75% versus previous 30 day period

Search interest for Welcure Drugs & Pharmaceuticals Ltd Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Welcure Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
-
-
-
-
-
-
24.55
0.88
21.21
299.91
65.62
-
Other Income
0.22
-
-
0.04
0.06
-
-
-
1.91
-
-
1.46
Total Income
0.22
-
-
0.04
0.06
-
24.55
0.88
23.12
299.91
65.62
1.46
Expenses
0.05
0.03
0.09
0.06
0.05
0.34
22.71
0.79
20.58
268.77
54.25
0.03
Operating Profit
-0.05
-0.03
-0.09
-0.06
-0.05
-0.34
1.84
0.09
0.63
31.14
11.37
-0.03
Operating Profit Margin %
0%
0%
0%
0%
0%
0%
7.49%
10.23%
2.97%
10.38%
17.33%
0%
Profit Before Interest, Tax and Depreciation
0.17
-0.03
-0.09
-0.02
-
-0.34
1.84
0.09
2.55
31.14
11.37
1.43
Depreciation
-
-
0.01
0.01
0.02
-
0.01
-
0.01
-
-
0.01
Profit Before Tax
0.17
-0.03
-0.1
-0.03
-0.02
-0.34
1.83
0.09
2.54
31.14
11.37
1.42
Tax Paid
-
-
-
-
-
-
-
0.05
-
7.84
2.86
0.36
Profit After Tax
0.17
-0.03
-0.1
-0.03
-0.02
-0.34
1.84
0.04
2.54
23.3
8.5
1.07
Total Net profit including share of profit / Loss from associate company
0.17
-0.03
-0.1
-0.03
-0.02
-0.34
1.84
0.04
2.54
23.3
8.5
1.07
EPS
0.12
-0.02
-0.01
-0.02
-0.01
-0.26
0.16
0.04
0.33
2.07
0.76
0.13
Actual EPS
0.12
-0.02
-0.01
-0.02
-0.01
-0.26
0.16
0.04
0.33
2.07
0.76
0.13
Adjusted EPS
0.01
-0
-0
-0
-0
-0.02
0.01
0
0.03
0.19
0.07
0.13
Diluted EPS
0.12
-0.02
-0.01
-0.02
-0.01
-0.26
0.16
0.04
0.33
2.07
0.76
0.13

Welcure Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
-
-
-
-
-
0.11
-
-
24.55
Other Income
-
-
-
-
-
-
0.24
0.09
1.91
Total Income
0.09
0.05
0.08
0.08
0.13
0.11
0.24
0.09
26.46
Expenses
0.06
0.07
0.08
0.09
0.08
0.08
0.13
0.23
23.67
Operating Profit
-0.06
-0.07
-0.08
-0.09
-0.08
0.03
-0.13
-0.23
0.88
Operating Profit Margin %
0%
0%
0%
0%
0%
27.27%
0%
0%
3.58%
Profit Before Interest, Tax and Depreciation
0.03
-0.02
-
-0.01
0.06
0.02
0.11
-0.14
2.79
Depreciation
-
-
-
-
-
-
-
0.04
0.01
Profit Before Tax
0.03
-0.02
-
-0.01
0.06
0.02
0.11
-0.18
2.78
Tax Paid
-
-
-
-
-
-
-
-
0.61
Profit After Tax
0.03
-0.02
-
-0.01
0.06
0.02
0.1
-0.17
2.17
Total Net profit including share of profit / Loss from associate company
0.03
-0.02
-
-0.01
0.06
0.02
0.1
-0.17
2.17
EPS
0.02
-0.02
-
-0.01
0.05
0.02
0.08
-0.13
0.36
Actual EPS
0.02
-0.02
-
-0.01
0.05
0.02
0.08
-0.13
0.36
Adjusted EPS
0
-0
-
-0
0
0
0.01
-0.01
0.03
Diluted EPS
0.02
-0.02
-
-0.01
0.05
0.02
0.08
-0.13
0.36

Welcure Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.05
0.02
-0.01
-
-0.01
0.04
0.02
0.11
-0.13
-222.03
Cash Flow from Investing Activities
0.03
-
-
-
-
-
-
-
0.17
-0.07
Cash Flow from Financing Activities
-
-
-
-
-
-
-
-0.17
-0.02
222.2
Net Cash Flow
-0.02
0.02
-0.01
-
-0.01
0.04
0.02
-0.06
0.02
0.11

Welcure Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
DII
0.01%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Public
99.99%
100%
100%
100%
100%
100%
100%
100%
100%
100%
100%
100%
Total Outstanding Shares
1,35,12,100
1,35,12,100
1,35,12,100
1,35,12,100
1,35,12,100
1,35,12,100
1,35,12,100
11,25,12,100
11,25,12,100
11,23,58,200
11,23,58,200
1,23,59,40,200
Total Shareholders
29,013
29,251
29,593
29,957
31,530
31,045
30,218
30,605
32,366
37,298
76,954
87,288

Welcure Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Welcure Drugs.

  • Welcure Drugs & Pharmaceuticals Ltd Earnings Results

    Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 2575% since last year same period to ₹1.07Cr in the Q3 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -87.41% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Welcure Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 100.00% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, Welcure Drugs stock has moved down by -39.7%

About Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs And Pharmaceuticals was established in June 1992 by D C Jain, Sanjeev Jain and Sandeep Jain. It offers a range of bulk drugs, drugs intermediates, pharmaceutical formulations and other products such as ampicillin, trimethoprim, amoxycillin, cloxacillin, ibuprofen, 6APA, WELSTAP X CLOX, ETHAMBUTOL RIFA Z, CETIRIZIN and NORTIN. The company raised Rs 4cr from a public issue in 1994, part finance a Rs 7cr project in Rajasthan and invest in its subsidiary A K Laboratories. To facilitate this expansion, the company issued a Rs 7.09cr rights issue of equity shares.

Apart from this, additional products like Stevioside, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF and XDRYL, were introduced in the year 2000–01. The company also entered into a collaboration agreement with Advanced Medical Care Inc, New Jersey, to set up joint venture facilities at their existing plant. In 2013, Welcure changed its marketing policy from sale through wholesale distributors to doorway sales, reaching every corner of the country through sales personnel and stockists. As of 2020, Welcure holds ISO 9002 certification with double accreditation from ABS Quality Evaluation Inc and Registrar of Accreditation Board of USA.

Revenue: ₹0.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1.07Cr as on December 2025 (Q3 FY26)
OrganisationWelcure Drugs & Pharmaceuticals Ltd
HeadquartersDelhi
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Welcure Drugs share price today?

Welcure Drugs share price today stands at ₹0.34 as on at the close of the market. Welcure Drugs share today touched a day high of ₹0.34 and a low of ₹0.34.

What is the 52 week high and 52 week low range for Welcure Drugs share?

Welcure Drugs touched a 52 week high of ₹1.44 and a 52 week low of ₹0.28. Welcure Drugs share price today i.e. is closed at ₹0.34, which is -76.39% down from its 52 week high and 21.43% up from its 52 week low.

What is Welcure Drugs's market capitalisation today?

Welcure Drugs market capitalisation is ₹43.26 Cr as on .

How to buy Welcure Drugs shares?

To buy Welcure Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524661 or Welcure Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Welcure Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Welcure Drugs trading volume today?

Welcure Drugs trading volume is 13.89L as on . This means that 13.89L shares of Welcure Drugs were bought and sold on the stock market during today's trading session.